The Relationship between Plasma Pentraxin 3 and Serum Amyloid P Levels and Disease Activity in Ankylosing Spondylitis

Table 5

Distribution of pentraxin 3 and serum amyloid P in patients with ankylosing spondylitis according to medical treatment.

	Anti-TNF-α (n = 71)	NSAID (n = 29)
PTX3, pg/mL, median (min-max)	2987.2 (10–20000.0)	2713.7 (10–12966.5)	0.623
SAP, pg/mL, median (min-max)	65.8 (37.4–300)	56.0 (43.1–303.7)	0.172

PTX3: pentraxin 3, SAP: serum amyloid P, anti-TNF-α: antitumor necrosis alpha, and NSAID: nonsteroidal anti-inflammatory drug.